Research Library
GHK-Cu research
6 articles to explore, with links to 7 original sources.
About GHK-Cu
GHK-Cu is the copper complex of glycyl-histidyl-lysine, a naturally occurring tripeptide. Sources connect it with collagen production, extracellular-matrix remodeling and wound-repair research, underpinning its prominence in skin-focused product descriptions.
Understand the science
Why binding copper made GHK interesting to cell researchers
GHK-Cu is the form of a naturally occurring three-amino-acid peptide when it is associated with copper. An older 1980 study asked whether the association could help explain why the peptide changed the behavior of cells in laboratory experiments.
1 source (1980)
Explore study findings
What a 2026 skin study could attribute to its copper peptide
GHK-Cu is a complex of a three-amino-acid peptide and copper. An August 2026 paper examined a cosmetic product containing the copper peptide alongside another active component. It reported skin measurements in people as well as findings from cells and isolated tissue.
1 source (2026)
Why a diabetic wound model studied the environment around the wound
GHK-Cu is a copper complex of a three-amino-acid peptide. In 2026, a nonclinical study evaluated a combination containing GHK-Cu in models of infected diabetic wounds. It asked how the local conditions in a wound relate to tissue repair.
1 source (2026)
What FDA's 2026 evaluation categories mean for GHK-Cu
The agency returned GHK-Cu to Category 1 for non-injectable forms. Category 1 in this document describes nominated bulk substances under evaluation.
2 sources (2026)
What patients and blinded evaluators saw after laser resurfacing
GHK-Cu is the copper complex of a three-amino-acid peptide. An older randomized study published in 2006 examined whether products containing this complex changed recovery or appearance after carbon dioxide laser resurfacing. Thirteen participants completed the study.
1 source (2006)
Check methods and identity
What a registered acute-wound study plans to measure
GHK-Cu is a three-amino-acid peptide bound to copper. A phase 2 study registered in February 2026 proposes to evaluate it for closure of acute skin wounds in healthy adults. Its public record describes a question and a planned comparison.
1 source (2026)
